These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21976726)

  • 21. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
    Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
    Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishing reliable miRNA-cancer association network based on text-mining method.
    Li L; Hu X; Yang Z; Jia Z; Fang M; Zhang L; Zhou Y
    Comput Math Methods Med; 2014; 2014():746979. PubMed ID: 24895499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
    Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
    Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
    BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the consistency of differential expression of microRNA detected in human cancers.
    Gong X; Wu R; Wang H; Guo X; Wang D; Gu Y; Zhang Y; Zhao W; Cheng L; Wang C; Guo Z
    Mol Cancer Ther; 2011 May; 10(5):752-60. PubMed ID: 21398424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
    Guan L; Tan J; Li H; Jin X
    Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
    Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
    Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved random forest-based computational model for predicting novel miRNA-disease associations.
    Yao D; Zhan X; Kwoh CK
    BMC Bioinformatics; 2019 Dec; 20(1):624. PubMed ID: 31795954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs and complex diseases: from experimental results to computational models.
    Chen X; Xie D; Zhao Q; You ZH
    Brief Bioinform; 2019 Mar; 20(2):515-539. PubMed ID: 29045685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the NCI-60 dataset for cancer-related microRNA and mRNA using expression profiles.
    Weng CW; Lee SC; Lee YL; Ng KL
    Comput Biol Chem; 2013 Jun; 44():15-21. PubMed ID: 23499870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data.
    Xiong L; Jiang W; Zhou R; Mao C; Guo Z
    Comput Biol Med; 2013 Sep; 43(9):1252-60. PubMed ID: 23930820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key genes and miRNAs markers of papillary thyroid cancer.
    Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
    Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.
    Li J; Lei K; Wu Z; Li W; Liu G; Liu J; Cheng F; Tang Y
    Oncotarget; 2016 Jul; 7(29):45584-45596. PubMed ID: 27329603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.